Astrazeneca pledges to fight patent ruling

Shares in drugs giant AstraZeneca today fell 4% after an American court ruled patents covering a key heart drug were invalid.

Astrazeneca pledges to fight patent ruling

Shares in drugs giant AstraZeneca today fell 4% after an American court ruled patents covering a key heart drug were invalid.

The court found that patents on Toprol XL – which were due to expire in September 2007 – were “unenforceable” in a case against rival drugmakers.

Already a subscriber? Sign in

You have reached your article limit.

Subscribe to access all of the Irish Examiner.

Annual €130 €80

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited